Elsevier Inc.

SHERPA: Unknown

People

  1. Berger
    Berger
  2. Schultz
    Schultz
  3. Al-Ahmadie
    Al-Ahmadie
  4. Iyer
    Iyer
  5. Solit
    Solit
  6. Bochner
    Bochner
  7. Donahue
    Donahue
  8. Goh
    Goh
  9. Pietzak
    Pietzak
  10. Sarungbam
    Sarungbam

Groups

  1. Computational Oncology Service (5)
  2. Epidemiology and Biostatistics (5)
  3. GSK Faculty (5)
  4. Human Oncology and Pathogenesis Program (5)
  5. Department of Medicine (4)
  6. Sloan Kettering Institute Postdocs (4)
  7. Solid Tumor Oncology Division (4)
  8. Surgery (4)
  9. Genitourinary Oncology Service (3)
  10. Survivorship Research (3)
Search Within
  1. "Computational Oncology Service"
  2. "Meeting abstract"
  3. "Michael Berger"
Formats
  1. Meeting Abstract (5)
Groups
  1. Computational Oncology Service (5)
  2. Epidemiology and Biostatistics (5)
  3. GSK Faculty (5)
  4. Human Oncology and Pathogenesis Program (5)
  5. Department of Medicine (4)
  6. Sloan Kettering Institute Postdocs (4)

More Groups

People
  1. Michael Berger (5)
  2. Nikolaus Schultz (5)
  3. David Solit (3)
  4. Gopakumar Iyer (3)
  5. Hikmat Al-Ahmadie (3)
  6. Alvin Goh (2)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (1)
  4. 2018 (1)
Publications
  1. European Journal of Cancer (2)
  2. Urologic Oncology: Seminars and Original Investigations (2)
  3. Journal of Thoracic Oncology (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ERBB2 alterations in non-muscle invasive bladder cancer are associated with a distinct genomic signature
    Meeting Abstract

    Alam, S. M.; Tallman, J.; Koll, F.; D'Souza, N.; de Jesus Escano, M.; Donahue, T.; Goh, A.; Sarungbam, J.; Berger, M.; Schultz, N.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Genomic characterization of high-grade Ta urothelial carcinoma with and without carcinoma in situ
    Meeting Abstract

    Tallman, J. E.; Alam, S. M.; Koll, F.; Baky, F. J.; D'Souza, N.; de Jesus Escano, M.; Donahue, T. F.; Goh, A. C.; Sarungbam, J.; Berger, M. F.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • HER2 as a therapeutic target in bladder cancer
    Meeting Abstract

    Chen, Z.; Tang, X.; Christin, J. R.; Gao, S. P.; Chu, C. E.; Berger, M. F.; Schultz, N. D.; Shen, M. M.; Al-Ahmadie, H. A.; Iyer, G.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Characterization of the genetic landscape of low mutation burden malignancies through multi-parallel genomic and immunologic analysis
    Meeting Abstract

    Trippett, T.; Berger, M.; Narendran, A.; Lyden, D.; Kovalchuk, O.; Bodour, S.; Laquaglia, M.; Ambati, S.; Schultz, N.; Roehrl, M.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save